Jeff Yass’s Pacer BioThreat Strategy ETF VIRS Stock Holding History

Jeff Yass’s Portfolio VIRS Stock Details VIRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-21,048	Closed	-$838K	–	13607
2024 Q3	$838K	Sell	21,048 -259	-1%	-$9.87K	﹤0.01%	7226
2024 Q2	$775K	Buy	21,307 +602	+3%	+$21.5K	﹤0.01%	7184
2024 Q1	$749K	Buy	20,705 +267	+1%	+$9.17K	﹤0.01%	7556
2023 Q4	$660K	Buy	20,438 +2,780	+16%	+$83.7K	﹤0.01%	7995
2023 Q3	$527K	Buy	17,658 +747	+4%	+$23.3K	﹤0.01%	8108
2023 Q2	$527K	Buy	16,911 +586	+4%	+$17.5K	﹤0.01%	8188
2023 Q1	$478K	Buy	16,325 +2,707	+20%	+$77.6K	﹤0.01%	8677
2022 Q4	$384K	Buy	13,618 +1,021	+8%	+$28.2K	﹤0.01%	8484
2022 Q3	$317K	Buy	+12,597	New	+$346K	﹤0.01%	9662

Jeff Yass's VIRS Position: Q4 2024 in Review

Jeff Yass sold out of Pacer BioThreat Strategy ETF (VIRS) in Q4 2024, closing a stake of 21,048 shares — an estimated $838K sold.

Jeff Yass first reported a position in VIRS in Q3 2022 and held it in 9 quarters. The position peaked at $838K in Q3 2024. 0 funds tracked by Wall St. Rank hold VIRS as of Q4 2024.

Jeff Yass reported no remaining Pacer BioThreat Strategy ETF position as of Q4 2024 after selling out during the quarter.
Jeff Yass sold 21,048 Pacer BioThreat Strategy ETF shares in Q4 2024, an estimated $838K.
Jeff Yass first reported a position in Pacer BioThreat Strategy ETF in Q3 2022 and held it in 9 quarters.
Jeff Yass's Pacer BioThreat Strategy ETF position peaked at $838K in Q3 2024.
0 funds tracked by Wall St. Rank held Pacer BioThreat Strategy ETF as of Q4 2024.

Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.